Pages

Friday, March 31, 2017

US FDA News: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device

Failure to activate or increased force needed to activate may have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis).
Read more: EpiPen and and EpiPen Jr Auto-Injector: Recall - Failure to Activate Device